142 results on '"Blasini R"'
Search Results
2. Tranforming medication data from the Meona HIS into FHIR resources
- Author
-
Beck, J, Blasini, R, Michel-Backofen, A, and Schneider, H
- Subjects
ddc: 610 ,FHIR ,Medicine and health ,medical informatics ,Mirth Connect ,Meona ,POLAR - Abstract
Introduction: Hospital information systems (HIS) are widely used at German hospitals to save information about patients, diagnostics, and therapies. Often this data is not saved in a structured way. Therefore, it is difficult to be compared or used for analyses. To help answer specific questions in [for full text, please go to the a.m. URL]
- Published
- 2022
- Full Text
- View/download PDF
3. NO-Donoren in der Therapie der chronischen Herzinsuffizienz
- Author
-
Blasini, R., Lehmann, G., and Schömig, A.
- Published
- 1997
- Full Text
- View/download PDF
4. Functional changes in left ventricular hypertrophy: diagnosis of impaired diastolic function in patients with hypertension
- Author
-
Blasini, R., Tiessen, V., and Schömig, A.
- Published
- 1993
- Full Text
- View/download PDF
5. Correlation between LDA and ultrasound heart catheter measurements in a stenosed arterial model
- Author
-
Liepsch, D., Poll, A., and Blasini, R.
- Subjects
Laser Doppler blood flowmetry -- Evaluation ,Cardiac catheterization -- Evaluation ,Coronary arteries -- Research ,Fluid dynamic measurements -- Evaluation ,Blood flow -- Measurement ,Engineering and manufacturing industries ,Science and technology - Abstract
Ultrasound heart catheters are used to measure the velocity in coronary arteries. However, the act of introducing a catheter into the vessel disturbs the very flow being measured. We used laser Doppler anemometry to measure the velocity distribution in an axially symmetric model, both with and without a catheter inserted. The catheter reduced the center-line velocity by as much as 60 percent at a distance of 2 mm downstream from the catheter, and by as much as 25 percent at a distance of 10 mm. This means the velocity measured with an ultrasound catheter does not show the maximum velocity of the undisturbed flow in the tube center. In the constriction, however, the measured velocities with the LDA and ultrasound catheter are almost the same. Thus, catheter measurements in the stenosis achieve accurate results. The velocity profile in the stenosed areas is flattened over nearly the whole cross section. The velocity is extremely reduced only close to the wall. The measurements outside of the stenosis lead to large differences which need to be studied carefully in the future. The disturbed flow finally disappeared 15 mm downstream of the catheter. The measurements were done at steady flow using a glycerine water solution with a dynamic viscosity of 4.35 mPas. In future studies, these experiments will be repeated for pulsatile flow conditions using non-Newtonian blood-like fluids.
- Published
- 1995
6. Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg
- Author
-
Sakmann, B., Schrader, J., Brenner, B., Murer, H., Boeckh, J., Handwerker, H. O., HonerjÄger, P., Dugas, M., Wang, G., DeLuca, A., Brinkmeier, H., Fakler, B., Pröbstle, T., Rüdel, R., Pohl, J. -A., Meves, H., Kroll, B., Bremer, S., Tümmler, B., Frömter, E., Schwegler, J. S., Steigner, W., Silbernagl, S., Pusch, Michael, Niemann, P., Schmidtmayer, J., Ulbricht, W., Hansen, G., Lönnendonker, U., Neumcke, B., Eickhorn, R., Hornung, D., Antoni, H., Penner, R., Neher, E., Takeshima, H., Nishimura, S., Numa, S., Melzer, W., Feldmeyer, D., Pohl, B., Zöllner, P., Müller, T. H., Swandulla, D., Misgeld, U, Ganitkevich, V. Ya., Isenberg, G., Cavalié, A., Allen, T. J. A., Trautwein, W., Pelzer, Siegried, Shuba, Yaroslav M., Asai, Tatsuya, Trautwein, Wolfgang, Brown, Arthur M., Birnbauner, Lutz, McDonald, Terence F., Pelzer, Dieter, Eckert, R., Hescheler, J., Rosenthal, W., Offermann, S., Krautwurst, D., Schultz, G., Kettenmahn, Helmut, Trotter, J., Verkhratsky, Alexe J N., Savtchenko, Alexej N., Verkhratsky, Alexej N., Schiefer, A., Klöckner, U., Partridge, L. D., SchÄfer, S., Jonas, P., Koh, D. S., Kampe, K., Hermsteiner, M., Vogel, W., Bauer, C. K., Schwarz, J. R., Fink, R. H. A., Wettwer, E., Weik, R., Schlatter, E., Bleich, M., Granitzer, M., Leal, T., Nagel, W., Crabbé, J., Lang, F., Kahn, E., Friedrich, F., Paulmichl, M., Hammerer, M., Maly, K., Grunicke, H., Böhm, T., Nilius, B., Gögelein, H., Dahlem, D., Weiss, H., Waldegger, S., Woell, E., Paulmichl, R., Ruppersberg, J. P., Schröter, K. H., Stocker, M., Pongs, O., Wittka, R., Boheim, G., Lichtinghagen, R, Augustine, C. K., Stühmer, W., Hoppe, Dorothe, Hoppe, D., Zittlau, K. E., Walther, C., Hatt, H., Franke, C., Quasthoff, S., Wischmeyer, E., Jockusch, H., Friedrich, M., Benndorf, K., Bollmann, G., Hirche, Hj., Hollunder-Reese, F., Mohrmann, M., Greger, R., Weber-Schürholz, S., Schürholz, T., Akabas, M., Landry, D., Al-Awqati, Q., Guse, A. H., Gercken, G., Meyerhof, W., Westphale, H. -J., Kerstins, U., Oberleithner, H., Tilmann, M., Kunzelmann, K., Klitsch, T., Siemen, D., Draguhn, A., Verdoorn, T. A., Pritchett, D. B., Seeburg, P. H., Malherbe, P., Möhler, H., Sakmann, B., Hatt H., Dudel, J., Stern, P., Zufall, F., Rosenheimer, J., Smith, D. O., Dörner, R., Ballanyi, K., Schlue, W. -R., Kalthof, B., Pott, L., Busch, C., Konno, T., Stenql, M., Reinhardt, Ch., Kaiser, H., Baumann, R., Wilimzig, M., Eichenlaub, R., Neumann, E., Lessmann, V., Gottmann, K., Dietzel, I. D., Keller, B. U., Yaari, Y., Konnerth, A., Backus, K. H., Giller, T., Knoflach, F., Pflimlin, P., Trübe, G., von Blankenfeld, G., Ymer, S., Sontheimer, H., Ewert, M., Seeburg, P. H., Kettenmann, H., Schneggenburger, R., Paschke, D., Hülser, D. F., Ubl, J., Kolb, H. A., Ströttchen, J., Boheim, S., Wehner, F., Guth, D., Kinne, R. K. H., Hülser, D. F., Polder, H. R., Bödeker, D., Hoppe, Susanne, Höller, H., Hampe, W., Ruf, H., Schulz, I., Dehlinger-Kremer, M., Ozawa, T., Vasilets, L., Schmalzing, G., MÄdefessel, K., Biel, H., Schwarz, W., Burckhardt, B. C., Stallmach, N., MairbÄurl, H., Hoffman, J. F., Schömig, E., Heuner, A., Göbel, B. O., Siffert, W., Butke, A., Hoffmann, G., zu Brickwedde, M. -K. Meyer, Vetter, H., Düsing, R., Rosskopf, D., Osswald, U., Steffgen, J., Koepsell, H., Martens, H., Rübbelke, M., GÄbel, G., Arens, J., Stabel, J., Fischer, Y., Thomas, J., Rose, H., Kammermeier, H., Munsch, Thomas, Deitmer, Joachim W., Engelmann, B., Duhm, J., Deitmer, Joachim W., Gunzel, D., Galler, S., Fischer, H., Clauss, W., Van Driessche, W., Köckerling, A, Schulzke, JD, Sorgenfrei, D, Fromm, M, Simon, B., Ganapathy, V., Leibach, F. H., Burckhardt, G., Krattenmacher, R., Voigt, Rosita, Dietrich, S., Leyssens, A., Zhang, S. L., Weltens, R., Steels, P., Hoffmann, B., Heinz, M., Habura, B., Dörge, A., Rechkemmer, G., von Engelhardt, W., StrauB, O., Wiederholt, M., Margineanu, D. -G., Van Driessche, W., Kreusel, K. M., Fromm, M., Lempart, U., Sorgenfrei, D., Hegel, U., Augustin, A. J., . Goldstein, R., Purucker, E., Lutz, J., Illek, B., Thiele, K -P., Schwealer, JS., Dittmer J., Bauer C., Eckardt, K. -U., Dittmer, J., Neumann, R., Bauer, C., Kurtz, A., Fromm, H., Schulzke, J. D., Clausen, P., Krohn, A., Lüderitz, S., Hierholzer, K., Kersting, U., Woinowski, L., Gro\mann, R., Bin, X. U., Ellendorff, F., Nitschke, R., Fröbe, U., Scholz, H., della Bruna, R., Ehmke, H., Persson, P. B., Seyfarth, M., Kirchheim, H. R., Dietrich, M. S., Parekh, N., Steinhausen, M., Bührle, C. P., Nobiling, R., Ullrich, K. J., Rumrich, G., Klöss, S., Papavassiliou, F., Hoyer, J., Schmitt, C., Jungwirth, A., Ritter, M., Westphale, H. J., Bevan, C., Theiss, C., Denek, Liliana, Schwegler, Johann S., SchÄfer, Roland, Augustin, Albert J., Heidland, August, Nafz, B., Just, A., Steidl, M., Pinggera, G., Gerstberger, R., Schütz, H., Simon, E., Lohrmann, E., Masereel, B., Delarge, J., Lang, H. J., Englert, H. C., Caliebe, D., Mályusz, M., Wrigge, P., Gronow, G., Klause N., Mályusz, M., Zinnert, H., Fagel, H., Jelkmann, W., Weiss, Ch., Augustin, A. J., Keil, R., Schmidt, W., Kröger, C., Brabant, E. G., Hilgendorf, A., Strauch, S., Lane, F., Prick, A., Golenhofen, N., Mildenberger, S., Schwegler, J. S., Flemming, B., Roloff, D., Wronski, T., Drews, G., Debuyser, A., Henquin, J. C., Jackson, M. B., DeRiemer, S. A., Schmid, A., Schnefel, S., Pröfrock, A., Hinsch, K. -D., Milz, J., Lamprecht, G., Seidler, U., Silen, W., Aziz, O., Reschke, W., Fischer, G., De Decker, N., Hayes, T., Coast, G., Van Kerkhove, E., von zur Mühlen, F., Eckstein, F., Hegel, U, Bentzel, CJ, Riecken, EO, Siemer, C., Rothenpieler, P., Smith, E., Lutnicki, K. R., Wróbel, J. T., Ledwożyw, A., PietraŚ, E., Sender, S., Jürgens, Klaus D., Kleinschmidt, T., Werkmeister, F., Kiwull-Schöne, H., Kiwull, P., Vahle, J., Ott, M., Zimmermann, R. E., Elsing, J. G., Million, D., Zillner, P., Thiel, M., Bardenheuer, H., Peter, K., Fandrey, J., Siegers, C. P., Rupp, H., Elimban, V., Dhalla, N. S., Morano, I., Agostini, B., Mühleisen, M., Mommaerts, W. F. H. M., Ono, K., Wussling, M., Schenk, W., Boldt, W., Lipp, P., Schüttler, K., Szymanski, G., Wendt-Gallitelli, M. F., Herzig, J. W., Depersin, H., Grupp, G., Grupp, I., Glitsch, H. G., Pusch, H., Zylka, Ch., Brāndle, M., Jacob, R., Stein, T., Isselhard, W., Sturz, J., Minor, T., Wingenfeld, P., Siegmund, B., Klietz, T., Schwartz, P., Piper, H. M., Linder, Christa, SchÄfer, Stefan, Heusch, Gerd, Becker, B. F., Reinholz, N., Raschke, P., Leipert, B., Gerlach, E., Dierberger, B., Gülch, R. W., Leverkus, M., Mitsuiye, T., Pohl, U., Wang, S. Y., Meyer, R., Haas, H. G., Christmann, H. Ph, Dörner, Th, Hock, D., Hertel, R., Gagelmann, M., Forssmann, W. G., Leijendekker, W. J., Kissling, G., Michel, H., Goetz, A., Freya, M., Fleckenstein-Grün, G., Schipke, Jochen D., Harasawa, Yasuhiko, Sugiura, Seiryo, Alexander, Joe, Burkhoff, Daniel, Kling, L., Müller-Beckmann, B., Schroth, M., Sponer, G., Böhm, E., Strein, K., Dorszewski, A., Arnold, G., Pike, G. K., Bryant, D. J., Roberts, M. L., Fink, R. H., Ross, Ch., Skyschally, A., Schulz, R., Linder, C., Heusch, G., Schipke, J. D., Burkhoff, D., Alexander, J., Gollnick, F., Peter, Kh., Franken-Weyers, R., Borst, M. M., Deussen, A., Pöpping, S., Hose, H., Strotmann, K. H., Lukascek, B., Karnath, T., Güttier, K., Klaus, W., Haverkampf, K., Guhlmann, M., Schmidt-Ott, S., Heuschen, U., Mall, G., Pfitzer, G., Rösch, J., Arner, A., Rüegg, J. C., Kröger, K., Schipke, J. D., ThÄmer, V., Ehring, Thomas, ThÄmer, Volker, Guth, B. D., Schnabel, Ph A., Schmiedl, A., Gebhard, M. M., Richter, J., Bretschneider, H. J., Guth, B. D., Oudiz, R. J., Schnabel, Ph., Richter, J ., Watanabe, H., Spahr, R., Piper, H. M., Obst, O., Mertens, H., Mülsch, A., Busse, R., Lamontagne, D., Herlan, K., Huang, A., Bassenae, E., Mackert, J. R. L., Schilling, L., Parsons, A. A., Wahl, M., Hock, D., Christmann, M. Ph., Thimm, F., Frey, M., Fleckenstein, a. A., Theilen, H., Göbel, U., Kuschinsky, W., Elbert, Th., Tafil-Klawe, M., Rau, H., Lutzenberger, W., Fleckenstein, A., Forst, H., Haller, M., Santjohanser, C., Lauterjung, L., Smieško, Y., Lang, D. J., Johnson, P. C., Schröck, H., Rau H., Elbert T., Geiger B, Lutzenberger W., Koch, G., Koralewski, H. E., Perschel, F. H., Wagner, K., Krüger, U., Albrecht, M., Hohlbach, G., Maassen, N., Foerster, M., Mühling, J., Bari, F., Pleschka, K., Schmidt, H. D., Gro\, H., Loock, W., Stick, C., Diefenbacher, U., Gronewold, D., Tobinsky, M., Walther-Behrends, A., Witzleb, E., Brummermann, M., Reinertsen, R. E., Rogausch, H., Rohn, W. M., Acker, H., Delpiano, M., Dufau, E., Hentschel, J., Heller, H., Schuster, K. -D., Siekmeier, R., Kronenberger, H., Lintl, H., Schiller-Scotland, Ch. F., Gebhart, J., Heyder, J., Meier-Sydow, J., Stahlhofen, W., Mottaghy, K., Geisen, C., Richter, W., Beckman, J., Marek, W., Ulmer, W. T., Thiele, A. E., Raschke, F., Peter, J. H., Hildebrandt, G., Kullmer, T., Kozianka-Burghof, G., Thiele, A. E., Schlaefke, M. E., Gnuschke, H., Schaefer, T., Schaefer, D., Schaefer, C., Bradley, Ronald J., Sterz, Raimund, Peper, Klaus, Benterbusch, R., Kraft, Th., Yu, L. C., Kuhn, H. J., Blankenbach, K., Asmussen, G., Kunze, I., Pieper, K. -S., Steinmetz, J., Schmidt, H., Krippeit-Drews, P., Hübschen, U., Nacimiento, A. C., Günzel, D., Rathmayer, W., Gaunitz, U., Költgen, D., Zachar, E., Soltau, B., De Martino, L., Hasselbach, W., Kössler, F., Lange, P., Küchler, G., Zeugner, C., Van Eyk, J., Hodges, R. S., Lorkovic, H., Clemens, N., Scheid, P., Noack, Th., Deitmer, P., Golenhofen, K., Lammel, E., Welling, Andrea, Felbel, Jochen, Hofmann, Franz, Katoch, S., Watanabe, T., Mandrek, K., Milenov, K., Hammer, K., Rössler, W., Sann, H., Pierau, Fr -K., Nguyen-Duong, H., Schneider, P., Stahl, F., Lepple-Wienhues, A., Korbmacher, C., Haller, H., Gebauer, M., Willner, U., Bialojan, C., Lengsfeld, M., Kyrtatas, V., Dartsch, Peter C., Boels, P. J., Fischer, W., Lenz, T., Thei\, U., Kreye, V. A. W., Ohkubo, T., Kupp, H., Vonderlage, M., Schreiner, V., Dorlöchter, M., Brinkers, M., Irintchev, A., Wernig, A., Langenfeld, B., Finger, W., Wolburg, H., Beer, A., Schwejda, Ch., Scheller, D., Heister, U., Tegtmeier, F., Knöpfel, Thomas, Spuler, Andreas, Grafe, Peter, GÄhwiler, Beat, Bijak, M., Misgeld, U., Müller, W., Rausche, G., Leweke, F M., Bingmann, D., Moraidis, I., Speckmann, E. -J., Madeja, M., Mu\hoff, U., Lehmenkühler, A, Kuhlmann, D., Hans, M., Lux, H. D., StrÄub, H., Waiden, J., Baker, R. E., Grantyn, R., Perouansky, M., Kraszewski, K, Lehmenkühler, Chr, Dodt, H. U., ZieglgÄnsberger, W., Pawelzik, H., ZieglgÄngsberger, W., Mann, K., Wiethölter, H., Albrecht, D., Dreier, J., Ficker, E., Beck, H., Corrette, B J., Dreyer, F., Repp, H., Dreessen, J., Augustine, G. J., Lehmenkühler, A., Büsselberg, D., Heimrich, B., Haas, H. L., Birnstiel, S., Haas, H. L., Schönrock, B., Altrup, U., Reith, H., Speckmann, E. -J., Alzheimer, C., Bruagencate, G. ten, Fruhstorfer, B., Mignot, E., Nishino, S., Dement, W. C., Guilleminault, C., Simon-Oppermann, Christa, Günther, Olaf, Stehle, J., Reuss, S., Seidel, A., Riemann, R., Vollrath, L., Reimer, Susanne, HölIt, Volker, Sonnhof, U., Krupp, J., Claus, H, Hinckel, P., Dick, H. B. H., Hiemke, C., Jussofie, A., Dorn, T., Uhlig, S., Witte, O. W., Bother B., Eiselt M., Witte H., Zwiener ö, Rother M, Eiseit H., Taghavy, A., KrÄtzer, A., Clusmann, H., Heinemann, U., Block, F., Sonatg, K. -H., Falkeristein, M., Hohnsbein, J., Hoormann, J., Frieling, A., Tarkka, I. M., Kullmann, W., Bromm, B., Hirsch, M. Chr, Wissing, H., Braun, H. A., Igelmund, P., Klu\mann, F. W., Ehrenstein, W. H., Yakimoff, N., Mateeff, S., Zeise, M. L., Arriagada, J., Teschemacher, A., ZieglgÄnsberger, W., Pöppelmann, T., Köhling, R., Boerrigter, P., Reith, H., Anders, K., Ohndorf, W., Dermietzel, R., Richter, D. W., Tölle, T. R., Castro-Lopes, J. M., Neuropharmakologie, Klinische, Sandkühler, J., Leah, J. D., Herdegen, T., Zimmermann, M., Vaitl, D., Gnippe, H., Herbert, M. K., Mengel, M. K. C., Kniffki, K. -D., Linke, R., Vahle-Hinz, C., Schenda, J., Matsumura, K., Herdegen, T., fu, Q. -G., Forster, C., Hutchison, W. D., Morton, C. R., Aschoff, J., Wilhelm, Z., Schwarzacher, S. W., Wasserschaff, M, Hörner, M., Kümmel, H., Windhorst, U., Feldman, J. L., Schmid, K., Foutz, A. S., Denavit-Saubié, M., Pak, M. A., Wehling, P., Evans, C., Bandara, G., Awiszus, F., Feistner, H., Heinze, H. -J., Illert, M., Wasserschaff, M., Kleinebeckel, D., Böhmer, G., Schauer, W., Abel, H. -H., Klü\endorf, D., Koepchen, H. P., Jarolimek, W, König, St, Czachurski, J., Seller, H., Meckler, R. L., McLachlan, E. M., Boczek-Funcke, A., HÄbler, H. -J., JÄnig, W., Michaelis, M., Dembowsky, K., Königr, S., Rau, Harald, HÄbler, H. -J., Unger, M., Merker, G., Roth, J., Zeisberger, E., Gao, H., Hunold, M., Kirchner, F., Takano, K., Schulze, K., Pokorski, M., Sakakibara, Y., Masuda, A., Morikawa, T., Ahn, B., Takaishi, S., Paulev, P. -E., Honda, Y., Flügge, G., Fuchs, E., König, S., Eysel, U. Th., Schmidt-Kastner, R., Skrandies, W., Geib, T., Baumann, C., Schmidt, K. -F., Knapp, A. G., Dowling, J. E., Kuba, M., Toyonaga, N., Kubová, Z., Ehrenstein, W. H., Jacobi, P., Schmidt, K. -F., Nöll, G. N., Baumann, Ch., Tabata, M., Martin, Ch., Meissl, H., Knottenberg, Th., Scheibner, H., Zenner, Hans P., Zimmennann, Ulrike, Gitter, Alfred H., Ding, D., Smolders, J. W. T., Klinke, R., Boekhoff, I., Raming, K., Krieger, J., Tareilus, E., Strotinann, J., Breer, H., Schild, D., DeSimone, J. A., Hellwig, S., Gitter, A. H., Plinkert, P. K., Zenner, H. P., Koltzenbwg, M., Pinter, E., SchÄfer, K., Braun, H. A., Necker, R., Hanesch, U., Heppelmann, B., Schmidt, R. F., Mense, S., Hoheisel, U., Steen, K. H., Anton, F., Reek, P. W., Handwerker, H. O., Lewin, G. R., McMahon, S. B., Heyer, G., Hornstein, O. P., Klement, W., Arndt, J. O., Maeerl, W., GrÄmer, G., Schepelmann, K., Me\linger, K., Schaible, H. -G., Treede, R. D., Meyer, R. A., Campbell, J. N., Claus, D., Neundörfer, B., Ernst, R., Tick-Waider, A. M., Bretschneider, F., Peters, R. C., Tennis, P. F. M., Teunis, P. F. M., Hoheisel, D., Scherotzke, R., Bub, A., Manzl, G., Forssmann, W. G., Jessen, C., Nuesslein, B., Schmidt, I., Wetzig, J., Reiser, M., Bregenzer, N., von Baumgarten, R. J., Mohr, E., Krzywanek, H., Warncke, G., Schuchmann, K. -L., Linow, H., Klu\mann, F. H., Redlin, U., Heldmaier, G., Bamler, A, Koller, A., Felber, S., Haid, C., Wicke, K., Raas, E., Xuemin, Wang, Kerning, Chen, Ying, Shi, Hanping, Shi, Warncke, Günther, Voisord, R., Dortsch, P. C., Betz, E., Karbach, U., Walenta, S., Gross, M. W., Mueller-Klieser, W., Vaupel, P., Okunieff, P., Mayer, W. -K., Stohrer, M., Krüger, W., Müller-Klieser, W., Strupp, M., Weial, P., Bostock, H., Piwernetz, K., Renner, R., Grafe, P., Lankers, J., Zangemeister, W., Kunze, K., Tries, S., Heinle, H., Beckerath, N. V., Maier-Rudolph, W., Mehrke, G., Günther, K., Goedel-Meinen, L., Daut, J., Piper, H. M., Kopp, A., Noll, T., Goellner, A., Gerlach, S., Teutsch, H. F., Schienger, K., Schwab, R., Höckel, M., Fotev, Z., Nienhaus, M., Kaczmarczyk, Gabriele, Richter, Dinah, Korte, Gabriele, Förther, J., Reinhardt, H. W., Schreiber, R., Rupp, J., Murphy, G., Fingerle, J., Kloiber, O., Miyazawa, T., Höhn-Berlage, M., Hossmann, K. -A., Schad, H., Heimisch, W., Blasini, R., Haas, F., Mendier, M., Spuler, A., Lehmann-Hom, F., Wolfram, U., Fenske, M., Sachser, N., Weis, Ch., Marktl, W., Kopta, B., Klammer, N., Rudas, B., Pohl, H., Nienartowicz, A., Moll, W., Klempt, M., Blum, S., Bühler, H., Lichtenstein, I., Novak, A., Siebe, H., Hierholzer, K., and Peper, K.
- Published
- 1990
- Full Text
- View/download PDF
7. Predictive models of Crohn’s disease in childhood
- Author
-
de Laffolie, J, Blasini, R, Schneider, N, Schneider, H, and Sohrabi, K
- Subjects
Epidemiologie ,ddc: 610 ,Medizinische Informatik ,610 Medical sciences ,Medicine ,digestive system diseases - Abstract
Introduction: The predictors of poor outcome (POPO) are recently considered to be important criteria in the choice of therapy for pediatric patients with Crohn's disease. These criteria include (POPO1) a deep colon ulceration at initial endoscopy, (POPO2) persistently severe disease despite [for full text, please go to the a.m. URL], 63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS)
- Published
- 2018
- Full Text
- View/download PDF
8. Predictive models for ulcerative colitis in childhood
- Author
-
de Laffolie, J, Blasini, R, Gross, R, Schneider, N, Schneider, H, and Sohrabi, K
- Subjects
Epidemiologie ,ddc: 610 ,Medizinische Informatik ,610 Medical sciences ,Medicine ,digestive system diseases - Abstract
Introduction: The predictors of poor outcome (POPO) have received increasing attention in the last few years. These are criteria that indicate a poor disease course for pediatric patients with Crohn’s Disease. For ulcerative colitis, no POPO criteria have been established so far. The aim of this[for full text, please go to the a.m. URL], 63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS)
- Published
- 2018
- Full Text
- View/download PDF
9. Entwicklung eines klinischen Registers am Beispiel Chronisch-entzündliche Darmerkrankungen bei pädiatrischen Patienten CEDATA
- Author
-
Blasini, R, Schwarz, B, Rupp, S, Fischer, P, Schneider, H, Gross, V, de Laffolie, J, Sohrabi, K, Blasini, R, Schwarz, B, Rupp, S, Fischer, P, Schneider, H, Gross, V, de Laffolie, J, and Sohrabi, K
- Published
- 2017
10. Tolerance to the Antiischemic Effect of Isosorbide Dinitrate during Continuous but not during Intermittent Oral Therapy
- Author
-
Blasini, R., Reiniger, G., Brügmann, U., Cohn, Jay N., editor, and Rittinghausen, Reiner, editor
- Published
- 1985
- Full Text
- View/download PDF
11. Kardiologie
- Author
-
Mathey, D. G., Kuck, K. H., Schofer, J., Krebber, H. J., Montz, R., Rodewald, G., Bleifeld, W., Eichstädt, H., Rutsch, W., Botsch, H., Felix, R., Schmutzler, H., Hofmann, M., Schuler, G., Schwarz, F., Mäurer, W., Mehmel, H., Senges, J., Tillmanns, H., Kübler, W., von Olshausen, K., Mehmel, H. C., Zimmermann, R., Harenberg, J., Kandler, J., Rebmann, T., Neuhaus, K. L., Tebbe, U., Sauer, G., Köstering, H., Kreuzer, H., Genth, K., Wetzel, E., Heene, D. L., Kober, G., Scherer, D., Hopf, R., Dowinski, S., Schmidt-Moritz, A., Kaltenbach, M., Schnellbacher, K., Roskamm, H., Beck, O. A., Steckmann, E., Hochrein, H., Weiß, B., Donat, K., Ziegler, W. J., Dirschinger, J., Fleck, E., Brügmann, U., Redl, A., Rudolph, W., Schanzenbächer, P., Liebau, G., Deeg, P., Kochsiek, K., Jansen, W., Osterspey, A., Tauchert, M., Schell, U., Schmid, G., Fuchs, M., Schulz, V., Kipshidze, N. N., Chapidze, G. E., Blasini, R., Froer, K. L., Wemper, J., Behrenbeck, D. W., Hombach, V., Hilger, H. H., Droste, C., Gohlke-Bärwolf, A., Stürzenhofecker, P., Samek, L., Betz, P., Schmuziger, M., Deist, H., Wüsten, B., Schaper, W., Gottwik, M.-G., Puschmann, S., Neumann, F., Farohs, B., Gottwik, M., Bertel, O., Burkart, F., Ritz, R., Baitsch, G., Gilfrich, H. J., Schuster, C. J., Kremer, G., Langenstein, B. A., Hanrath, P., Hall, D., Ibrahim, Z., Meinertz, T., Schmitt, B., Kasper, W., Treese, N., Rückel, A., Zehender, M., Hofmann, T., Pop, T., Bethge, K.-P., Lichtlen, P. R., Kotzur, J., Kuebart, I., Theisen, F., Haufe, M., Theisen, K., Weber, M., Jahrmärker, H., Thormann, J., Schlepper, M., Kramer, W., Neuss, H., Wester, H.-A., Mouselimis, N., Steinbeck, G., Manz, M., Lüderitz, B., Höpp, H.-W., Braun, V., Djonlagic, H., Potratz, J., Lander, B., Hoffmann, J., Dageförde, J., Diedrich, K.-W., Wege, G., Haerten, K., Borggrefe, M., Breithardt, G., Weyers, F. J., Abendroth, R.-R., Heuer, H., Gülker, H., Thale, J., Meyer, M., Weiß, U., Bender, F., Bubenheimer, P., Görnandt, L., Erbei, R., Schweizer, P., Lambertz, H., Langen, H.-J., Meyer, J., Effert, S., and Schlegel, Bernhard, editor
- Published
- 1982
- Full Text
- View/download PDF
12. Wirkung von akuter und chronischer Behandlung mit Isosorbiddinitrat in Retardform bei Patienten mit Angina pectoris
- Author
-
Rudolph, W., Blasini, R., Froer, K.-L., Brügmann, U., Mannes, A., Hall, D., Engel, Heinz Jürgen, editor, Schrey, Alfred, editor, and Lichtlen, Paul Robert, editor
- Published
- 1982
- Full Text
- View/download PDF
13. Effects of Acute and Chronic Administration of Isosorbide Dinitrate, Sustained-Release Form, in Patients with Angina Pectoris
- Author
-
Rudolph, W., Blasini, R., Froer, K.-L., Bruegmann, U., Mannes, A., Hall, D., Lichtlen, P. R., editor, Engel, H.-J., editor, Schrey, A., editor, and Swan, H. J. C., editor
- Published
- 1981
- Full Text
- View/download PDF
14. Buchbesprechung
- Author
-
Blasini, R.
- Published
- 1991
- Full Text
- View/download PDF
15. Tolerance to the Antiischemic Effect of Isosorbide Dinitrate during Continuous but not during Intermittent Oral Therapy
- Author
-
Blasini, R., primary, Reiniger, G., additional, and Brügmann, U., additional
- Published
- 1985
- Full Text
- View/download PDF
16. Der Gehalt fibrinolytisch und proteolytisch wirkender Enzyme in gesundem und tumorösem Nierengewebe
- Author
-
Tauber, R., primary, Stemberger, A., additional, Blasini, R., additional, Wriedt-Lübbe, I., additional, and Blümel, G., additional
- Published
- 1980
- Full Text
- View/download PDF
17. Der Gehalt fibrinolytisch und proteolytisch wirkender Enzyme in gesundem und tumorösem Nierengewebe
- Author
-
Tauber, R., Stemberger, A., Blasini, R., Wriedt-Lübbe, I., Blümel, G., Mauermayer, W., and Frohmüller, H., editor
- Published
- 1980
- Full Text
- View/download PDF
18. Experimentelle Untersuchungen über die organspezifische Anreicherung von Kininogenasen im Hoden-Nebenhodenbereich*
- Author
-
BLASINI, R., primary, SCHMELLER, M.-L., additional, PFEIFFER, Chr., additional, WRIEDT-LÜBBE, I., additional, HUBER, P., additional, and BLÜMEL, G., additional
- Published
- 2009
- Full Text
- View/download PDF
19. Untersuchungen über die gewebeständige Plasminogenaktivator- und Plasmininhibitoraktivität von Gelenkkapseln bei verschiedenen Gelenkerkrankungen
- Author
-
Blasini, Ch., primary, Glas, K., additional, Blasini, R., additional, Haas, S., additional, Wriedt-Lübbe, I., additional, and Blümel, G., additional
- Published
- 2008
- Full Text
- View/download PDF
20. Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation.
- Author
-
Blasini, R., primary, Neumann, F. J., additional, Richardt, G., additional, Schmitt, C., additional, Paloncy, R., additional, and Schomig, A., additional
- Published
- 1996
- Full Text
- View/download PDF
21. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.
- Author
-
Schömig, A, primary, Kastrati, A, additional, Mudra, H, additional, Blasini, R, additional, Schühlen, H, additional, Klauss, V, additional, Richardt, G, additional, and Neumann, F J, additional
- Published
- 1994
- Full Text
- View/download PDF
22. Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter.
- Author
-
Mudra, H, primary, Klauss, V, additional, Blasini, R, additional, Kroetz, M, additional, Rieber, J, additional, Regar, E, additional, and Theisen, K, additional
- Published
- 1994
- Full Text
- View/download PDF
23. Buchbesprechungen
- Author
-
Blasini, R.
- Published
- 1988
- Full Text
- View/download PDF
24. Intravascular Ultrasonography in Tumor Staging
- Author
-
Lehner, K., primary, Gerhardt, P., additional, and Blasini, R., additional
- Published
- 1992
- Full Text
- View/download PDF
25. Intravasaler Ultraschall (IVUS): Beurteilung der Infiltration von Tumoren in die Gefäßwand
- Author
-
Lehner, K., primary, Gerhardt, P., additional, and Blasini, R., additional
- Published
- 1992
- Full Text
- View/download PDF
26. Einfluß eines Herzkatheters auf die Geschwindigkeitsprofile in einem stenotisierten Arterienmodell
- Author
-
Liepsch, D., primary, Poll, A., additional, and Blasini, R., additional
- Published
- 1991
- Full Text
- View/download PDF
27. Global and regional ventricular function following intracoronary application of papaverine
- Author
-
SCHAD, H, primary, HEIMISCH, W, additional, HAAS, F, additional, BLASINI, R, additional, and MENDLER, N, additional
- Published
- 1991
- Full Text
- View/download PDF
28. Does intracoronary papaverine affect the function of myocardial areas with reduced coronary flow reserve?
- Author
-
Schad, H., primary, Heimisch, W., additional, Blasini, R., additional, Haas, F., additional, and Mendler, N., additional
- Published
- 1990
- Full Text
- View/download PDF
29. Untersuchungen �ber die gewebest�ndige Plasminogenaktivator- und Plasmininhibitoraktivit�t von Gelenkkapseln bei verschiedenen Gelenkerkrankungen.
- Author
-
Blasini, Ch., Glas, K., Blasini, R., Haas, S., Wriedt-L�bbe, I., and Bl�mel, G.
- Published
- 1981
- Full Text
- View/download PDF
30. Untersuchungen über die gewebeständige Plasminogenaktivator- und Plasmininhibitoraktivität von Gelenkkapseln bei verschiedenen Gelenkerkrankungen
- Author
-
Blasini, Ch., Glas, K., Blasini, R., Haas, S., Wriedt-Lübbe, I., and Blümel, G.
- Published
- 1981
- Full Text
- View/download PDF
31. Über die Bedeutung der fibrinolytischen Aktivität der Lunge unter dem Aspekt des akuten Atemnotsyndroms
- Author
-
Haas, S., Blasini, R., Krieglsteiner, P., and Blümel, G.
- Published
- 1985
- Full Text
- View/download PDF
32. Effects of Acute and Chronic Administration of Isosorbide Dinitrate, Sustained-Release Form, in Patients with Angina Pectoris
- Author
-
U. Bruegmann, A. Mannes, K.-L. Froer, Blasini R, W. Rudolph, and Hall D
- Subjects
business.industry ,Anginal attacks ,Exercise capacity ,medicine.disease ,Angina ,Vascular reactivity ,Regimen ,Anesthesia ,medicine ,In patient ,Isosorbide dinitrate ,business ,Depression (differential diagnoses) ,medicine.drug - Abstract
Based on clinical studies of long-term treatment with orally administered nitrates indicating a reduction in the rate of anginal attacks, nitrate consumption, or ST-segment depression as well as an increased exercise capacity, this regimen has been considered useful in the prophylactic treatment of angina pectoris [2, 4, 8, 12]. Moreover, it has been reported that during chronic treatment with nitrates, acute administration of an additional dose, regardless of application form, favorably influences the rate of anginal attacks as well as ST-segment depression and the duration of exercise with maintained efficacy [1, 3, 9]. Apparently discrepant are the withdrawal symptoms, resulting from developed tolerance and observed in industrial workers chronically exposed to nitrates, the mechanism of which has been attributed to a resetting of vascular reactivity [7].
- Published
- 1981
33. Tolerance to the Antiischemic Effect of Isosorbide Dinitrate during Continuous but not during Intermittent Oral Therapy
- Author
-
Brügmann U, Blasini R, and Reiniger G
- Subjects
Chronic congestive heart failure ,business.industry ,Plasma concentration ,medicine ,Isosorbide dinitrate ,Pharmacology ,business ,Galenic formulation ,Oral therapy ,medicine.drug - Abstract
In 1980 a placebo-controlled double-blind study was published by us demonstrating a clear development of tolerance to the antiischemic effect of isosorbide dinitrate (ISDN) in slow-release (s.r.) form during long-term treatment with 20, 40, or 60 mg three times daily [1, 11]. These results were at that time actively discussed as they showed that the widely used — but at that time not proven — administration of ISDN s.r. t.i.d. is equivalent to a placebotreatment. This study induced us to make further investigations to assess the following: 1. whether tolerance, independent of the galenic formulation, is an inherent property of ISDN longterm treatment; 2. the temporal course of development and reversal of tolerance; 3. whether the antiischemic and hypotensive effects of ISDN show a different response in respect to tolerance development; 4. the interaction between nitrate plasma concentration and tolerance development; 5. the clinical significance of a possible cross-tolerance to the antiischemic effect of sublingually administered nitroglycerin (GTN); and 6. whether tolerance can be avoided by intermittent administration.
- Published
- 1985
34. Wirkung von akuter und chronischer Behandlung mit Isosorbiddinitrat in Retardform bei Patienten mit Angina pectoris
- Author
-
K.-L. Froer, Hall D, W. Rudolph, Brügmann U, A. Mannes, and Blasini R
- Abstract
Auf Grund klinischer Studien, die bei Patienten mit koronarer Herzerkrankung eine Reduktion der Angina-pectoris-Anfallshaufigkeit, des Nitratverbrauchs und der ST-Streckensenkung sowie einen Anstieg der Belastungstoleranz unter Langzeittherapie mit oral verabreichten Nitraten nachwiesen, wurde diese Therapieform als effektiv zur Angina-pectoris-Prophylaxe angesehen [2, 4, 8, 12].
- Published
- 1982
35. Emergent interventional transcatheter revascularization in acute right coronary artery dissection after blunt chest trauma.
- Author
-
Thorban S, Ungeheuer A, Blasini R, and Siewert JR
- Published
- 1997
- Full Text
- View/download PDF
36. Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy
- Author
-
Drzezga, A. E., Blasini, R., Ziegler, S. I., Bengel, F. M., Picker, W., and markus schwaiger
37. Über die Bedeutung der fibrinolytischen Aktivität der Lunge unter dem Aspekt des akuten Atemnotsyndroms
- Author
-
Blasini, R., primary, Krieglsteiner, P., primary, Blümel, G., primary, and Haas, S., additional
- Published
- 1985
- Full Text
- View/download PDF
38. Tissue proteases demonstrated by a histochemical method using chromogenic substrates
- Author
-
Blasini, R., primary, Stemberger, A., additional, Wriedt-Lübbe, I., additional, and Blümel, G., additional
- Published
- 1978
- Full Text
- View/download PDF
39. Fibrinolytic and Kallikrein Activities in Human Carcinoma Kidneys
- Author
-
Blasini, R., Stemberger, A., Tauber, R., Wriedt-Lübbe, I., and Blümel, G.
- Published
- 1979
- Full Text
- View/download PDF
40. Restenosis after coronary placement of various stent types.
- Author
-
Kastrati, Adnan, Mehilli, Julinda, Dirschinger, Josef, Pache, Jürgen, Ulm, Kurt, Schühlen, Helmut, Seyfarth, Melchior, Schmitt, Claus, Blasini, Rudolf, Neumann, Franz-Josef, Schömig, Albert, Kastrati, A, Mehilli, J, Dirschinger, J, Pache, J, Ulm, K, Schühlen, H, Seyfarth, M, Schmitt, C, and Blasini, R
- Subjects
- *
CORONARY restenosis , *SURGICAL stents - Abstract
Coronary stent implantation is being performed in an increasing number of patients with a wide spectrum of clinical and lesion characteristics. A variety of stent designs are now available and continuous efforts are being made to improve the stent placement procedure. The objective of this study was to perform a comprehensive analysis of the relation between clinical, lesion, and procedural factors, and restenosis after intracoronary stenting in a large and unselected population of patients. A consecutive series of 4,510 patients with coronary stent placement was analyzed. Exclusion criteria were only a failed procedure and an adverse outcome within the first month after the intervention. Follow-up angiography was performed in 80% of patients at 6 months. Clinical, lesion, and procedural data from all 3,370 patients (4,229 stented lesions) with follow-up angiography were analyzed in a logistic regression model for restenosis (> or =50% diameter stenosis). Clinical factors contributed to the predictive power of the model much less than lesion and procedural factors. The strongest risk factor for restenosis was a small vessel size, with a 79% increase in the risk for a vessel of 2.7 mm versus a vessel of 3.4 mm in diameter. Stent design was the second strongest factor; the incidence of restenosis ranged from 20.0% to 50.3% depending on the stent type implanted. In conclusion, this study demonstrates the predominant role of lesion and procedural factors in determining the occurrence of restenosis after coronary stent placement. Among these factors, stent design appears to play a particularly important role in the hyperplastic response of the vessel wall. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
41. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
- Author
-
Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, and Ulm K
- Published
- 1996
42. Deficiencies in Electronic Medical Record Inpatient List Capabilities Negatively Impact Patient Safety, Resident Education, and Wellness.
- Author
-
Davalos RA 3rd, Aden J, Pluta N, Blasini R, Schroeder P, and Cognetti DJ
- Subjects
- Retrospective Studies, Humans, Male, Orthopedics education, Female, Education, Medical, Graduate methods, Texas, Trauma Centers, Internship and Residency, Electronic Health Records, Patient Safety
- Abstract
Objective: Electronic medical records (EMRs) have streamlined workflows for health care professionals, yet their full potential is not always actualized. Modern EMRs are often capable of generating automated prepopulated inpatient lists, however if these capabilities are not made available to inpatient teams or not designed with the end user in mind, resident physicians may be left to create alternative, manual solutions to ensure reliable and efficient care. The purpose of the current study was to longitudinally compare the impact of both manual and automated inpatient lists on resident education, wellness, and patient safety., Design: Retrospective standardized surveys were administered to resident physicians in the orthopedic surgery department at a level I trauma center over a 3-year period to evaluate the impact of various automated and manual list iterations coinciding with changes to the EMR. Data collected included post graduate year (PGY) status, arrival time to work, daily time spent preparing and updating the list, perceived impact on patient safety, resident workload, education, and sleep. We compared manual versus automated list data with unpaired t-tests and chi-squared tests., Setting: The study was conducted at Brooke Army Medical Center, a level 1 trauma center in San Antonio, Texas. It is an Academic Medical Center and the Department of Defense's largest medical facility., Participants: A total of 71 surveys were collected from 33 orthopedic surgery residents in all levels of training., Results: Intern list prep time in the morning was 27 ± 16 minutes for the automated list (n = 17) vs 72 ± 21 minutes for the manual lists (n = 23) (p < 0.0001). Total time spent by interns updating the list for the entire day was on average 83 minutes for the automated list (n = 17) vs 196 minutes for the manual lists (n = 23) (p < 0.0001). In addition, 86% of interns felt the time spent on the manual list impacted their education, with 96% stating that it directly impacted the amount of time they had to study and 100% agreed that it negatively impacted their sleep (n = 23). Only 48% of interns (n = 23) were satisfied with the performance of the manual lists compared to 94% satisfaction (n = 17) with the automated list. Further, 87% of interns felt the manual list negatively impacted patient care and negatively affected their job satisfaction. In comparison, 59% of interns felt the automated list improved their job satisfaction. Ultimately, for an intern an automated list versus a manual list affords them an extra 106 minutes per day for education, sleep, or other activities. PGY2 residents and above noted similar trends regarding their experience with the lists., Conclusions: The benefits of utilizing automated inpatient lists as determined by our study are improved efficiency in the morning with less preparation and maintenance throughout the day. Additionally, with automated lists there was more perceived time for education and sleep, with improved job satisfaction. Most importantly, respondents felt that automated lists were safer for patient care when compared to manual lists. This should compel further research and efforts into improving automated EMR tracking lists in hospitals. In summary, as compared to the automated electronic medical record inpatient list, manual lists resulted in substantially more preparation time and maintenance throughout the day thereby negatively impacting resident education and quality of life, while raising concerns for patient safety., (Copyright © 2024 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
43. User Requirements for an Electronic Patient Recruitment System: Semistructured Interview Analysis After First Implementation in 3 German University Hospitals.
- Author
-
Stein A, Blasini R, Strantz C, Fitzer K, Gulden C, Leddig T, and Hoffmann W
- Subjects
- Humans, Germany, Male, Female, Adult, Interviews as Topic, Middle Aged, Surveys and Questionnaires, Clinical Trials as Topic methods, Hospitals, University, Patient Selection
- Abstract
Background: Clinical trials are essential for medical research and medical progress. Nevertheless, trials often fail to reach their recruitment goals. Patient recruitment systems aim to support clinical trials by providing an automated search for eligible patients in the databases of health care institutions like university hospitals. To integrate patient recruitment systems into existing workflows, previous works have assessed user requirements for these tools. In this study, we tested patient recruitment systems KAS+ and recruIT as part of the MIRACUM (Medical Informatics in Research and Care in University Medicine) project., Objective: Our goal was to investigate whether and to what extent the 2 different evaluated tools can meet the requirements resulting from the first requirements analysis, which was performed in 2018-2019. A user survey was conducted to determine whether the tools are usable in practice and helpful for the trial staff. Furthermore, we investigated whether the test phase revealed further requirements for recruitment tools that were not considered in the first place., Methods: We performed semistructured interviews with 10 participants in 3 German university hospitals who used the patient recruitment tools KAS+ or recruIT for at least 1 month with currently recruiting trials. Thereafter, the interviews were transcribed and analyzed by Meyring method. The identified statements of the interviewees were categorized into 5 groups of requirements and sorted by their frequency., Results: The evaluated recruIT and KAS+ tools fulfilled 7 and 11 requirements of the 12 previously identified requirements, respectively. The interviewed participants mentioned the need for different notification schedules, integration into their workflow, different patient characteristics, and pseudonymized screening lists. This resulted in a list of new requirements for the implementation or enhancement of patient recruitment systems., Conclusions: Trial staff report a huge need of support for the identification of eligible trial participants. Moreover, the workflows in patient recruitment differ across trials. For better suitability of the recruitment systems in the workflow of different kinds of trials, we recommend the implementation of an adjustable notification schedule for screening lists, a detailed workflow analysis, broad patient filtering options, and the display of all information needed to identify the persons on the list. Despite criticisms, all participants confirmed to use the patient recruitment systems again., (©Alexandra Stein, Romina Blasini, Cosima Strantz, Kai Fitzer, Christian Gulden, Torsten Leddig, Wolfgang Hoffmann. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 27.09.2024.)
- Published
- 2024
- Full Text
- View/download PDF
44. recruIT: A cloud-native clinical trial recruitment support system based on Health Level 7 Fast Healthcare Interoperability Resources (HL7 FHIR) and the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM).
- Author
-
Gulden C, Macho P, Reinecke I, Strantz C, Prokosch HU, and Blasini R
- Subjects
- Humans, Health Level Seven, Software, Patient Selection, Health Information Interoperability, Clinical Trials as Topic, Cloud Computing
- Abstract
Background: Clinical trials (CTs) are foundational to the advancement of evidence-based medicine and recruiting a sufficient number of participants is one of the crucial steps to their successful conduct. Yet, poor recruitment remains the most frequent reason for premature discontinuation or costly extension of clinical trials., Methods: We designed and implemented a novel, open-source software system to support the recruitment process in clinical trials by generating automatic recruitment recommendations. The development is guided by modern, cloud-native design principles and based on Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) as an interoperability standard with the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) being used as a source of patient data. We evaluated the usability using the system usability scale (SUS) after deploying the application for use by study personnel., Results: The implementation is based on the OMOP CDM as a repository of patient data that is continuously queried for possible trial candidates based on given clinical trial eligibility criteria. A web-based screening list can be used to display the candidates and email notifications about possible new trial participants can be sent automatically. All interactions between services use HL7 FHIR as the communication standard. The system can be installed using standard container technology and supports more sophisticated deployments on Kubernetes clusters. End-users (n = 19) rated the system with a SUS score of 79.9/100., Conclusion: We contribute a novel, open-source implementation to support the patient recruitment process in clinical trials that can be deployed using state-of-the art technologies. According to the SUS score, the system provides good usability., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals.
- Author
-
Boeker M, Zöller D, Blasini R, Macho P, Helfer S, Behrens M, Prokosch HU, and Gulden C
- Subjects
- Humans, Hospitals, University, Treatment Outcome, Multicenter Studies as Topic, Interrupted Time Series Analysis, Patient Selection
- Abstract
Background: As part of the German Medical Informatics Initiative, the MIRACUM project establishes data integration centers across ten German university hospitals. The embedded MIRACUM Use Case "Alerting in Care - IT Support for Patient Recruitment", aims to support the recruitment into clinical trials by automatically querying the repositories for patients satisfying eligibility criteria and presenting them as screening candidates. The objective of this study is to investigate whether the developed recruitment tool has a positive effect on study recruitment within a multi-center environment by increasing the number of participants. Its secondary objective is the measurement of organizational burden and user satisfaction of the provided IT solution., Methods: The study uses an Interrupted Time Series Design with a duration of 15 months. All trials start in the control phase of randomized length with regular recruitment and change to the intervention phase with additional IT support. The intervention consists of the application of a recruitment-support system which uses patient data collected in general care for screening according to specific criteria. The inclusion and exclusion criteria of all selected trials are translated into a machine-readable format using the OHDSI ATLAS tool. All patient data from the data integration centers is regularly checked against these criteria. The primary outcome is the number of participants recruited per trial and week standardized by the targeted number of participants per week and the expected recruitment duration of the specific trial. Secondary outcomes are usability, usefulness, and efficacy of the recruitment support. Sample size calculation based on simple parallel group assumption can demonstrate an effect size of d=0.57 on a significance level of 5% and a power of 80% with a total number of 100 trials (10 per site). Data describing the included trials and the recruitment process is collected at each site. The primary analysis will be conducted using linear mixed models with the actual recruitment number per week and trial standardized by the expected recruitment number per week and trial as the dependent variable., Discussion: The application of an IT-supported recruitment solution developed in the MIRACUM consortium leads to an increased number of recruited participants in studies at German university hospitals. It supports employees engaged in the recruitment of trial participants and is easy to integrate in their daily work., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
46. Evaluation of Eligibility Criteria Relevance for the Purpose of IT-Supported Trial Recruitment: Descriptive Quantitative Analysis.
- Author
-
Blasini R, Strantz C, Gulden C, Helfer S, Lidke J, Prokosch HU, Sohrabi K, and Schneider H
- Abstract
Background: Clinical trials (CTs) are crucial for medical research; however, they frequently fall short of the requisite number of participants who meet all eligibility criteria (EC). A clinical trial recruitment support system (CTRSS) is developed to help identify potential participants by performing a search on a specific data pool. The accuracy of the search results is directly related to the quality of the data used for comparison. Data accessibility can present challenges, making it crucial to identify the necessary data for a CTRSS to query. Prior research has examined the data elements frequently used in CT EC but has not evaluated which criteria are actually used to search for participants. Although all EC must be met to enroll a person in a CT, not all criteria have the same importance when searching for potential participants in an existing data pool, such as an electronic health record, because some of the criteria are only relevant at the time of enrollment., Objective: In this study, we investigated which groups of data elements are relevant in practice for finding suitable participants and whether there are typical elements that are not relevant and can therefore be omitted., Methods: We asked trial experts and CTRSS developers to first categorize the EC of their CTs according to data element groups and then to classify them into 1 of 3 categories: necessary, complementary, and irrelevant. In addition, the experts assessed whether a criterion was documented (on paper or digitally) or whether it was information known only to the treating physicians or patients., Results: We reviewed 82 CTs with 1132 unique EC. Of these 1132 EC, 350 (30.9%) were considered necessary, 224 (19.8%) complementary, and 341 (30.1%) total irrelevant. To identify the most relevant data elements, we introduced the data element relevance index (DERI). This describes the percentage of studies in which the corresponding data element occurs and is also classified as necessary or supplementary. We found that the query of "diagnosis" was relevant for finding participants in 79 (96.3%) of the CTs. This group was followed by "date of birth/age" with a DERI of 85.4% (n=70) and "procedure" with a DERI of 35.4% (n=29)., Conclusions: The distribution of data element groups in CTs has been heterogeneously described in previous works. Therefore, we recommend identifying the percentage of CTs in which data element groups can be found as a more reliable way to determine the relevance of EC. Only necessary and complementary criteria should be included in this DERI., (©Romina Blasini, Cosima Strantz, Christian Gulden, Sven Helfer, Jakub Lidke, Hans-Ulrich Prokosch, Keywan Sohrabi, Henning Schneider. Originally published in JMIR Formative Research (https://formative.jmir.org), 31.01.2024.)
- Published
- 2024
- Full Text
- View/download PDF
47. Implementation of inclusion and exclusion criteria in clinical studies in OHDSI ATLAS software.
- Author
-
Blasini R, Buchowicz KM, Schneider H, Samans B, and Sohrabi K
- Subjects
- Humans, Patient Selection, Software
- Abstract
Clinical trials are essential parts of a medical study process, but studies are often cancelled due to a lack of participants. Clinical Trial Recruitment Support Systems are systems that help to increase the number of participants by seeking more suitable subjects. The software ATLAS (developed by Observational Health Data Sciences and Informatics) can support the launch of a clinical trial by building cohorts of patients who fulfill certain criteria. The correct use of medical classification systems aiming at clearly defined inclusion and exclusion criteria in the studies is an important pillar of this software. The aim of this investigation was to determine whether ATLAS can be used in a Clinical Trial Recruitment Support System to portray the eligibility criteria of clinical studies. Our analysis considered the number of criteria feasible for integration with ATLAS and identified its strengths and weaknesses. Additionally, we investigated whether nonrepresentable criteria were associated with the utilized terminology systems. We analyzed ATLAS using 223 objective eligibility criteria from 30 randomly selected trials conducted in the last 10 years. In the next step, we selected appropriate ICD, OPS, LOINC, or ATC codes to feed the software. We classified each criterion and study based on its implementation capability in the software, ensuring a clear and logical progression of information. Based on our observations, 51% of the analyzed inclusion criteria were fully implemented in ATLAS. Within our selected example set, 10% of the studies were classified as fully portrayable, and 73% were portrayed to some extent. Additionally, we conducted an evaluation of the software regarding its technical limitations and interaction with medical classification systems. To improve and expand the scope of criteria within a cohort definition in a practical setting, it is recommended to work closely with personnel involved in the study to define the criteria precisely and to carefully select terminology systems. The chosen criteria should be combined according to the specific setting. Additional work is needed to specify the significance and amount of the extracted criteria., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
48. RD-MON - Building a Rare Disease Monitor to Enhance Awareness for Patients with Rare Diseases in Intensive Care.
- Author
-
Blasini R, Michel-Backofen A, Schneider H, and Marquardt K
- Subjects
- Humans, Intensive Care Units, Data Management, Hospitals, University, Rare Diseases diagnosis, Rare Diseases therapy, Critical Care
- Abstract
Rare diseases are commonly defined by an incidence of less than 5/10000 inhabitants. There are some 8000 different rare diseases known. So even if a single rare disease is seldom, together they pose a relevant problem for diagnosis and treatment. This is especially true if a patient is treated for another common disease. University hospital of Gießen is part of the CORD-MI Project on rare diseases within the German Medical Informatics Initiative (MII) and a member of the MIRACUM consortium within the MII. As part of the ongoing Development for a clinical research study monitor within the use case 1 of MIRACUM, the study monitor has been configured to detect patients with rare diseases during their routine clinical encounters. The goal was to send a documentation request to the corresponding patient chart within the patient data management system for extended disease documentation to enhance clinical awareness for the patients' potential problems. The project was started in late 2022 and has so far been successfully tuned to detect patients with Mucoviscidosis and place notifications within the patient chart of the patient data management system (PDMS) on intensive care units.
- Published
- 2023
- Full Text
- View/download PDF
49. Building a Comprehensive Clinical Data Repository Using FHIR, LOINC and SNOMED.
- Author
-
Michel-Backofen A, Pellizzari T, Zohner J, Blasini R, and Marquardt K
- Subjects
- Hospitals, University, Humans, Software, Systematized Nomenclature of Medicine, Logical Observation Identifiers Names and Codes, Medical Informatics
- Abstract
In 2018 the University Hospital of Giessen (UHG) moved its hospital information system from an in-house solution to commercial software. The introduction of MEONA and Synedra-AIM allowed for the successful migration of clinical documents. The large pool of structured clinical data has been addressed in a second step and is now consolidated in a HAPI-FHIR server and mapped to LOINC and SNOMED for semantic interoperability in multicenter research projects, especially the German Medical Informatics Initiative (MII) and the Medical Informatics in Research and Care in University Medicine (MIRACUM) consortium.
- Published
- 2022
- Full Text
- View/download PDF
50. Patient Recruitment System for Clinical Trials: Mixed Methods Study About Requirements at Ten University Hospitals.
- Author
-
Fitzer K, Haeuslschmid R, Blasini R, Altun FB, Hampf C, Freiesleben S, Macho P, Prokosch HU, and Gulden C
- Abstract
Background: Clinical trials are the gold standard for advancing medical knowledge and improving patient outcomes. For their success, an appropriately sized cohort is required. However, patient recruitment remains one of the most challenging aspects of clinical trials. Information technology (IT) support systems-for instance, patient recruitment systems-may help overcome existing challenges and improve recruitment rates, when customized to the user needs and environment., Objective: The goal of our study is to describe the status quo of patient recruitment processes and to identify user requirements for the development of a patient recruitment system., Methods: We conducted a web-based survey with 56 participants as well as semistructured interviews with 33 participants from 10 German university hospitals., Results: We here report the recruitment procedures and challenges of 10 university hospitals. The recruitment process was influenced by diverse factors such as the ward, use of software, and the study inclusion criteria. Overall, clinical staff seemed more involved in patient identification, while the research staff focused on screening tasks. Ad hoc and planned screenings were common. Identifying eligible patients was still associated with significant manual efforts. The recruitment staff used Microsoft Office suite because tailored software were not available. To implement such software, data from disparate sources will need to be made available. We discussed concrete technical challenges concerning patient recruitment systems, including requirements for features, data, infrastructure, and workflow integration, and we contributed to the support of developing a successful system., Conclusions: Identifying eligible patients is still associated with significant manual efforts. To fully make use of the high potential of IT in patient recruitment, many technical and process challenges have to be solved first. We contribute and discuss concrete technical challenges for patient recruitment systems, including requirements for features, data, infrastructure, and workflow integration., (©Kai Fitzer, Renate Haeuslschmid, Romina Blasini, Fatma Betül Altun, Christopher Hampf, Sherry Freiesleben, Philipp Macho, Hans-Ulrich Prokosch, Christian Gulden. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 20.04.2022.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.